Initial hiv treatment regimen

Common Questions and Answers about Initial hiv treatment regimen

hiv

Avatar n tn Patient #1 had a 95% reduction three days post treatment and 89% reduction seven days post treatment. The initial viral load for patient 1 was 5.3 x 10(5) viral units per ml of blood (IU/ml). Patient 1’s viral load seven days post treatment was 5.7 x 10(4) IU/ml. Patient #2 had a 85% reduction three days post treatment and 50% reduction seven days post treatment. The initial viral load for patient 2 was 9.2 x 10(6) IU/ml. Patient 2’s viral load seven days post treatment was 4.6 x 10(6) IU/ml.
2207631 tn?1369848423 For genotype 1 treatment naive patients, the treatment will be Sofosbuvir in combination with RBV and peg-IFN for patients with genotype 1, 4, 5 and 6 HCV infection. So the next new treatment to come to market in early 2014 for genotype 1 patients will have peg-interferon. http://www.medhelp.
Avatar f tn //www.hcvguidelines.org/full-report/initial-treatment-hcv-infection-patients-starting-treatment ----------------------------------------------------------------------------------------------------- INITIAL TREATMENT OF HCV INFECTION IN PATIENTS STARTING TREATMENT V. Genotype 5 or 6 Few data are available to help guide decision-making in patients infected with HCV genotype 5 or 6.
Avatar n tn Then explain your situation and maybe they can quarterback the tx with the fellow (I'm assuming a doc) who treats you for HIV. Nothing rocket science about HCV treatment, and I would think any doctor could administer the protocol IF given the correct "recipe" by a hepatologist and if the hepatologist is kept in the loop during tx.. Often a consulting doctor will not charge on phone follow-ups with another doctor.
Avatar m tn At the same time, most people who get syphilis do not get HIV. Was a HIV blood test done at the time of your initial evaluation? If so and you had a negative HIV blood test at the time your syphilis blood test was positive, that is strong evidence you did not get HIV although further testing is recommended. 2. What would be your recommended screening/testing dates to know that I am not infected? See above. A re-test for HIV is appropriate. 3. Am I overreacting?
Avatar m tn combined with an apparently negative viral load test, your prognosis is excllent as long as you continue your treatment regimen. That should end this thread. Take care and stay safe. Continue to be wise in partner selection and condom use; there's really no excuse for new unsafe exposures to syphilis or any other STD.
29837 tn?1414538248 He also mentioned that it will be at least six years before there’s a treatment without Interferon and the nasty Ribavirin. Can you wait? To his3707 As to your question of how do you go about getting the "compassionate use" of Telaprivir before its release? Aside from begging, you have your doctor fill and present a series of documents to the FDA and eventually Vertex. Search my archives on this and it will tell you everything, including where you can download the documents, etc...
Avatar m tn My apologies on posting hiv questions on the std forum, but i believe since the initial symptoms was of std, I posted it here. So you are implying i could relax and not think of contracting hiv or syphilis anymore? even if i tested just 1 1/2 week post exposure for hiv?
Avatar m tn I learned you are not supposed to pee for a certain amount of time before you go in, and I was at the cutoff mark, so I am thinking my initial Ghono/Chlamydia results may be inaccurate. Would a urine culture or test show trichomoniasis or syphillis also do you think an STI can cause these types of low grade fever or does that mean a virus? I know my exposure was low risk but I am scared because I know when you have caught something that your chances of having another infection go up.
Avatar m tn 5 months as Doctor told me that this treatment will be given under there supervision , please suggest which treatment is suitable under these report.Also with vaccine this problem will be solved and how long i have to take this treatment.
748543 tn?1463449675 For the past few weeks I have been throwing around ideas as to the best way to respond to this matter. You see a recent article ( Feb.3 , 2009 NY times) titled "Best treatment for TMJ May be Nothing" nearly made me clench my jaw to pieces. While well written, I found that the author, Ms. Brody, relied heavily on out dated and narrow perspective supplied to her by a small group of dentists.
Avatar n tn unprotected insertive vag with CSW, 25march,..on meds 27th in am, end regimen 24th negative initial, (all antibody testing), - 2, -4, -6, -9, -11, -12, -14, -16, i would be totally confident with the 3 month neg, but i read everywhere it may take up tp 6 months because i messed with my immune system by taking the antiviral medications. i also read that there has only been a couple incidents of prolonged or delayed seroconversion, but where occupational in origin.
Avatar m tn AS THE CENTERS FOR DISEASE CONTROL AND PREVENTION prepares to release revised annual statistics about new HIV infections in the United States (in 2005 the number of new infections was 20% to 50% higher than previously reported--possibly as high as 60,000), HIV increasingly settles into the American consciousness as a manageable disease.
Avatar f tn I would like to know how important it is to all of you to know your exact VL during treatment at 4 and 8 weeks. If you have a PCR that measures down to <50IU/ml, are you content with a Pass/Fail until that week 12? This is the scenario I'm in for and I'm not happy about it, I want to know my exact VL count at 4 weeks and 8 weeks if I fail, as in I'm above <50IU/ml. Is this reasonable or am I getting uptight for nothing?
173930 tn?1196341998 Survey seems consistent with what I've seen posted here. Most telling to me is that 40% reported feeling worse after treating than before: 29% reported feeling about the same; and 31% reported feeling better after treatment. What that means is that around 2 out of 3 people felt either worse or no different after treating. This should be a reality check for those who treat primarily because of the so-called extra-hepatatic symptons, i.e. to feel better.
Avatar m tn Many experts believe that reducing key viral proteins can revive patients' adaptive immune response and potentially lead to a functional cure of chronic HBV infection with a finite treatment regimen.
Avatar n tn I am now thinking of the worst possible outcome : HIV, dont know how long more I can take this.
Avatar f tn AbbVie is well-positioned to explore combinations and co-formulations of these medicines. Ritonavir Use in the Treatment of HIV Ritonavir is in a class of medicines called the HIV protease inhibitors. Ritonavir is used in combination with other anti-HIV medicines to treat people with human immunodeficiency virus (HIV) infection. Ritonavir is for adults and for children greater than 1 month in age and older.
Avatar m tn Daily daclatasvir (60 mg*) plus sofosbuvir (400 mg) for 12 weeks is a Recommended regimen for treatment-naïve patients with HCV genotype 3 infection who do not have cirrhosis. Rating: Class I, Level A Daily fixed-dose combination of sofosbuvir (400 mg)/velpatasvir (100 mg) for 12 weeks is a Recommended regimen for treatment-naïve patients with HCV genotype 3 infection who do not have cirrhosis.
Avatar m tn GT2 _______________________________ Excerpt only shown for GT2 Please go the links to read the complete info for GT2 and the other GT's Recommended regimen for treatment-naive patients with HCV genotype 2 infection. Daily daclatasvir (60 mg*) and sofosbuvir (400 mg) for 12 weeks is recommended for treatment-naive patients with HCV genotype 2 infection who cannot tolerate RBV.
Avatar n tn 3/22/2015 1/10/17 7/3/17 5/10/18 2/4/19 Reactive Equivocal Non-Reactive Non-Reactive Reactive 1:2 1:1 1:1 I keep shots of Penicillian sometimes 3 sometimes 1
Avatar m tn (Dieterich, 2014c) Thus, results from HCV monoinfection studies largely justify the recommendations for HIV/HCV coinfection (discussed in the Initial Treatment and Retreatment sections). Discussion specific to HIV/HCV coinfection studies is included here.
Avatar n tn how many days after initial exposure did you begin nPEP treatment?
144210 tn?1273092382 Among those who completed treatment, subjects in the double-dose arm had a higher end-of-treatment response rate (45% vs 20%) and SVR rate (40% vs 18%) compared with subjects receiving standard therapy. Adverse events were similar in both arms. Conclusion “Twice-weekly peginterferon-alpha-2a is associated with better early virologic response with similar safety profiles when compared with standard therapy,” the researchers concluded.
Avatar m tn Viral Genetics believes that its investigational HIV/AIDS drug based on TNP, called VGV-1, represents a unique approach to treating HIV due to the apparently novel mechanism, low toxicity profile, simple dosing regimen, and short-course of treatment. As a type of immune-based therapy, it focuses on boosting the immune system to allow the body to fight HIV more efficiently. VGV-1 has been studied in five human clinical trials for the treatment of HIV / AIDS. Online at www.viralgenetics.
Avatar f tn First, HCV is not known to be capable of archiving its genome as do HIV or hepatitis B virus. Data suggest that after treatment withdrawal, treatment-emergent substitutions decline in relative abundance over time and that wild-type virus regains its predominance in the majority of cases. However, this may take 2-3 years, and subtype 1a tends to return to wild type more slowly.
29837 tn?1414538248 The specific drugs used in the retreatment regimen should be tailored to the results of this testing as described below. Treatment duration of 24 weeks is recommended and, unless contraindicated, weight-based RBV should be added.
154668 tn?1290119595 Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen - Combination of R7227, protease inhibitor, and R7128, nucleoside polymerase inhibitor, shows significant potency in reducing viral load in patients with hepatitis C - NUTLEY, N.J., BRISBANE, Calif., and PRINCETON, N.J., April 25 /PRNewswire-FirstCall -- Roche, InterMune, Inc.
Avatar m tn The average improvement is CD4 typically is slower. Often there is an initial rise in the frest 1-2 months of treatment, but not necessarily; and after about 2 months, the rise averages 50-100 cells/mm3 per year. Also, the rise tends to be slower in people with higher viral loads at the start of treatment. To my knowledge, there is no evidence that life stresses have any effect on it.